SCHEMBL5543338

SCHEMBL5543338

CCCCCCCCNC(=O)c1ccc2cc(O)c(C(=O)OC)cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.53
XDH P47989 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
MGLL Q99685 1/20 0.50
NCEH1 Q6PIU2 1/20 0.49
NAAA Q02083 4/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
CA2 P00918 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709548 1.00 APP (0.53) APPXDHL3MBTL1MGLLNCEH1
SCHEMBL5694756 1.00 APP (0.53) APPXDHL3MBTL1MGLLNCEH1
SCHEMBL7157450 0.90 NAAA (0.60) APPXDHL3MBTL1NCEH1NAAA
SCHEMBL5694739 0.88 NAAA (0.53) APPXDHL3MBTL1NCEH1NAAA
SCHEMBL5539564 0.88 NAAA (0.53) APPXDHL3MBTL1NCEH1NAAA
SCHEMBL14599479 0.88 NAAA (0.53) APPXDHL3MBTL1NCEH1NAAA
SCHEMBL5709554 0.87 NAAA (0.53) APPXDHL3MBTL1NCEH1NAAA
SCHEMBL5694738 0.83 NAAA (0.57) APPL3MBTL1NAAACA2
SCHEMBL14599480 0.83 SMN1; SMN2 (0.54) APPXDHL3MBTL1NAAAHDAC3
SCHEMBL7158417 0.82 NAAA (0.53) NAAAHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169523-B2 electrophotographic toners comprising binder resins, colorants and charge control agents consisting of naphthol derivatives, having excellent negative chargeability, dispersion in and compatibility with binders KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2007-01-30 US disclosed
EP-1048694-B1 AZO COMPOUNDS AND PROCESS FOR PRODUCING THE SAME UENO SEIYAKU OYO KENKYUJO KK (JP) 2006-06-07 EP disclosed
US-20050147909-A1 Charge controllers UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2005-07-07 US disclosed
EP-1500988-A1 CHARGE CONTROLLERS KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-01-26 EP disclosed
US-6409812-B1 MONOAZO DYE; PAINTS, INK JETS, COLOR FILTERS; ELECTROGRAPHY; DIAZOTIZATION KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2002-06-25 US disclosed
EP-1048694-A1 AZO COMPOUNDS AND PROCESS FOR PRODUCING THE SAME KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2000-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050147909-A1 Charge controllers CECR2, NCAPH, COL1A1 APP 4335/4885XDH 1955/4885L3MBTL1 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.